A new research collaboration between India and Sweden is using artificial intelligence to accelerate the discovery of peptide-based therapeutics for pneumonia, aiming to shorten drug development timelines and combat drug-resistant infections.
Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a "long-term" opportunity in India's fast-evolving obesity and cardiometabolic therapy market, even as price competition in the glucagon-like peptide-1 (GLP-1) segment intensified.
'We recently launched Yesintek in the immunology space.'
'However, we have seen weakness in our active pharmaceutical ingredients business.'
Green vegetables contain a high amount of soluble and insoluble fiber to balance your good and bad gut bacteria.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances